Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Anyone see reverse split coming?
View:
Post by N0taP00p on May 05, 2023 10:55am

Anyone see reverse split coming?

Considering the difficulty they had raising money last time, anyone think they may  reverse split and then raise via a different route like the Nasdaq? Like 1:4 or 1:5?  They of course would need to ask the shareholders first. I would vote yes.   If they're still working on compiling data, I just don't see the money lasting beyond this quarter. They need someone savvy in raising funds, this close to potential BTD approval.  

In the meantime, IBRX has almost tripled in a month. D-Day must be near.
Comment by ggrellette on May 05, 2023 11:35am
Sadly a RSS is now on the table IMHO. Why do I say that because MAJOR support @ 25 cents got broken and it has not rebounded. This tells me something is not correct or something bad is coming our way and what could it be if it is not the science then it has to do with the stock. Thus it maybe a sell should it get back to 27 or 28 cents. The only people who have made anymoney here are those who ...more  
Comment by gebremeskel on May 05, 2023 11:40am
Not going to happen basher boy. You haven't raised the spectre of a reverse split for years. Do your bosses think the time is finally right to revivify this old chestnut? We've all heard it before. Considering the difficulty basher boy has been having raising the alarm among longs so far, does anyone think this lame attempt has any chance of working?
Comment by ggrellette on May 05, 2023 2:07pm
Don't be too over confident about NO RSS. Sadly that is when it happens just when you think it will not.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250